Enterprise Stent Implantation in the Treatment of Carotid Artery Stenosis With Ischemic Stroke

• Status: Completed
• Trial end date: 2015-12-01
• Target enrollment: 0
• Participant gender: All

Summary

To investigate the long-term effects of intracranial implantation of Enterprise stent system versus antiplatelet medication on neurologic deficits, daily living abilities, and carotid artery stenosis in patients with atherosclerotic ischemic stroke.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Beijing Chao Yang Hospital
• Treatments: Aspirin

Criteria

Inclusion Criteria:

• Atherosclerotic plague-caused carotid artery stenosis

• Severe carotid artery stenosis (unilateral stenosis > 70%) diagnosed according to angiography

• Age 18-75 years

• Of either sex

• Provision of informed consent regarding trial procedure

Exclusion Criteria:

• Non-atherosclerotic intracranial artery stenosis

• Severe cognitive or mental disorder

• Severe cardiovascular, hepatic, renal, or blood system diseases

• Pregnant or lactating

• Hemorrhagic disease or unable to receive anticoagulation or antiplatelet aggregation treatment

• Allergy to stent material

• Unable to or declined to cooperate with follow-up examination

• Unable to provide informed consent because of intellectual disability or language disorder